: President The Stock Exchange of Thailand According to JAS Asset Public Company Limited (the “Company”) Meeting Resolution No. 7/2019 on 11 November 2019, the resolution to certify the Company’s financial
Ratio (Time) 1.0 1.4 Quick Ratio (Time) 2.6 4.7 Collection Period (Day) 18.8 20.5 Stock Turnover Period (Day) 9.1 8.1 Payment Period (Day) 29.0 32.1 Profitability Ratio Gross Profit Margin (%) 11.4 19.8
Attention: President The Stock Exchange of Thailand CH. Karnchang Public Company Limited (“the Company”) and its subsidiaries would like to clarify the consolidated operating result and financial position for
and 2017 are 143.90 million THB and 318.86 million THB respectively, resulting in gross margin of 17.66% and 15.39%. Cost of sales can be broken down for turnkey business and for supply and maintenance
the second half of the year. However, government expenditure was slightly decline as well as the contraction on agricultural and construction sector. The Thai economy in 2018 is expected to expand more
information, {A} purchased 10,000 JASH16 Futures contracts whose underlying was the JAS stock before attending the Board?s meeting. JAS later disclosed the information on such dividend payment to the SET. The
decrease from the same period of 2017 of 11.1%. Total revenues were 518.3 million baht decline from the same period last year at 5.5%. However, this year the Company has more income from food and beverage
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Management discussion on 2017 operating results To The President of Stock Exchange of Thailand For 2017 operating performance, Matching Maximize Solution Public Company Limited (the Company) posted a net loss
receivables as of 30 June 2019 were Baht 11,480 million, a decrease of Baht 78 million or 0.7% down from the balance as of 31 December 2018. Most of the outstanding balance of trade and other receivables